Gedik, M. E. Et Al. 2024. Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. CANCER RESEARCH , no.9 , 1475-1490.

Gedik, M. E., Saatci, O., Oberholtzer, N., ÜNER, M., Caliskan, O. A., Cetin, M., ... Aras, M.(2024). Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. CANCER RESEARCH , no.9, 1475-1490.

Gedik, Mustafa Et Al. "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer," CANCER RESEARCH , no.9, 1475-1490, 2024

Gedik, Mustafa E. Et Al. "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer." CANCER RESEARCH , no.9, pp.1475-1490, 2024

Gedik, M. E. Et Al. (2024) . "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer." CANCER RESEARCH , no.9, pp.1475-1490.

@article{article, author={Mustafa Emre Gedik Et Al. }, title={Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer}, journal={CANCER RESEARCH}, year=2024, pages={1475-1490} }